download report - Istituto Pasteur
download report - Istituto Pasteur
download report - Istituto Pasteur
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
R. Silvestri - Indole nucleus as a selected pharmacophore for the design of novel highly potent anti-viral agents active against HIV-1<br />
drawing substituent(s) at position(s) 4 and 5 of the<br />
indole is currently in progress.<br />
Inhibitors of Tubulin Polymerization.<br />
Microtubules (MTs) are essential cytoskeletal polymers<br />
that are made of repeating α, β-tubulin (TB) heterodimers<br />
and are present in all eukaryotes. The crucial<br />
role of MTs in vital cellular functions for tumor<br />
cells, including mitosis, motility and cell-cell contacts,<br />
has made of MT interfering agents (MIAs) one of the<br />
best classes of cancer chemotherapeutic drugs available<br />
to date. A large number of chemically diverse<br />
compounds are able to bind TB or MTs and inhibit<br />
proliferation by acting on the mitotic spindle. Some of<br />
these compounds (vinca alkaloids, colchicine) inhibit<br />
MT polymerization, whereas others (taxanes) stabilize<br />
MTs. While drugs that act on the vinca and taxane<br />
sites have well-established roles in the treatment<br />
of human cancers, the therapeutic potential of the<br />
colchicine site in cancer treatment has yet to be realized.<br />
Recently, we have <strong>report</strong>ed arylthioindoles<br />
(ATIs) as a new class of potent inhibitors of tubulin<br />
polymerization and the growth of some carcinoma<br />
cells that bind to colchicine site on β-tubulin close to<br />
its interface with α-tubulin. Fist generation ATIs<br />
were characterized by (i) an ester function at position<br />
2 of the indole nucleus; (ii) a 3-arylthio group; (iii) an<br />
appropriate substituent on the indole nucleus.<br />
Focusing our attention on amino derivatives related to<br />
combretastatin A-4, we designed and synthesized second<br />
generation of ATI derivatives, bearing a hydrogen<br />
atom or a methyl group at position 2 of the indole<br />
nucleus. New ATIs were synthesized by a two-step<br />
procedure. O-Ethyl-S-(3,4,5-trimethoxyphenyl) carbonodithioate<br />
was transformed into 3,4,5trimethoxythiophenol<br />
by heating at 65 °C in aqueous<br />
ethanol in the presence of sodium hydroxide. This<br />
mixture was made acidic with 6 N HCl and treated at<br />
25°C with the appropriate indole while adding dropwise<br />
an aqueous iodine-potassium iodide solution. The<br />
new compounds strongly inhibited tubulin polymerization,<br />
with activity in the low micromolar range,<br />
comparable to the effects of colchicine and combretastatin<br />
A-4. Derivatives bearing a halogen atom or a<br />
small alkyl or ether group at position 5 of the indole<br />
nucleus, were also potent inhibitors of MCF-7<br />
124<br />
cell growth. For example, 5-bromo-3-[(3,4,5trimethoxyphenyl)thio]-1H-indole<br />
showed tubulin<br />
polymerization IC 50 = 1.6 µM and growth of MCF-<br />
7 cells IC 50 = 43 nM, and inhibited [ 3 H]colchicine<br />
binding at 65%. Cell cycle analysis revealed an accumulation<br />
of HeLa cells in the G2/M phase at 24 h and<br />
polyploidization at 48 h. At 24 h, inhibition of tubulin<br />
polymerization had not caused extensive apoptosis,<br />
suggesting that impaired cell viability might occur<br />
through a “mitotic catastrophe”. Molecular modelling<br />
studies showed that, despite the absence of the ester<br />
moiety, the second generation ATIs bind into the<br />
colchicine site in the same orientation as the first generation<br />
ones. Binding to β-tubulin involved formation<br />
of a hydrogen bond between the indole and Thr179<br />
and positioning of the trimethoxy phenyl group in a<br />
hydrophobic pocket near Cys241. The synthesis of<br />
new derivatives obtained by bioisosteric replacement<br />
of the sulfur bridge with either carbonyl or methylene,<br />
and some related groups, and the indole nucleus<br />
with differently substituted pyrrole and imidazole<br />
rings is currently in progress.<br />
Selected publications<br />
La Regina G, Coluccia A, Piscitelli F, Bergamini A,<br />
Sinistro A, Cavazza A, Maga G, Samuele A, Zanoli S,<br />
Novellino E, Artico M, Silvestri R. Indolyl aryl sulfones<br />
as HIV-1 non-nucleoside reverse transcriptase<br />
inhibitors: role of two halogen atoms at the indole<br />
ring in developing new analogues with improved<br />
antiviral activity. J Med Chem. 2007, 50:5034-8.<br />
La Regina G, Edler MC, Brancale A, Kandil S,<br />
Coluccia A, Piscitelli F, Hamel E, De Martino G,<br />
Matesanz R, Díaz JF, Scovassi AI, Prosperi E,<br />
Lavecchia A, Novellino E, Artico M, Silvestri R.<br />
Arylthioindole inhibitors of tubulin polymerization.<br />
3. Biological evaluation, structure-activity relationships<br />
and molecular modeling studies. J Med Chem.<br />
2007, 50: 2865-74.<br />
Ragno R, Coluccia A, La Regina G, Silvestri R.<br />
Indolyl aryl sulphones as HIV-1 reverse transcriptase<br />
inhibitors: docking and 3D QSAR studies. Exp<br />
Opin Drug Discovery 2007, 2:87-114.